Cardiff Oncology (CRDF) Non-Current Assets (2011 - 2026)

Cardiff Oncology has reported Non-Current Assets for 15 years, with the latest figure at $1.8 million in Q4 2025.

• Quarterly Non-Current Assets fell 17.79% year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.9 million (down 41.9% YoY) and the FY2025 annual result came in at $1.8 million, down 17.79% from the prior year.
• Non-Current Assets slipped to $1.8 million in Q4 2025 per CRDF's latest filing, from $2.0 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $4.9 million in Q4 2022 and troughed at $863000.0 in Q2 2021.
• A 5-year average of $3.2 million and a median of $3.6 million in 2021 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets jumped 345.77% in 2022, then plunged 49.44% in 2024.
• Over 5 years, Non-Current Assets stood at $3.4 million in 2021, then jumped by 43.61% to $4.9 million in 2022, then dropped by 13.9% to $4.2 million in 2023, then slumped by 49.44% to $2.1 million in 2024, then declined by 17.79% to $1.8 million in 2025.
• According to Business Quant data, Non-Current Assets over the past three periods registered $1.8 million, $2.0 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.